The ability of the oxime HI-6 to reduce tabun-induced acute neurotoxic signs and symptoms was compared with the neuroprotective efficacy of two combinations of oximes (HI-6 + trimedoxime, HI-6 + K203) using a functional observational battery. Tabun-induced neurotoxicity and the neuroprotective effects of HI-6 alone, and HI-6 combined with trimedoxime or K203, in rats poisoned with tabun at a sublethal dose (200 microg/kg i.m.; 80% of LD50 value), were monitored by the functional observational battery at 24 hours following tabun challenge. The results indicate that both oxime mixtures tested, combined with atropine are able to allow tabun-poisoned rats to survive for 24 hours following tabun challenge, while one non-treated tabun poisoned rat and one tabun-poisoned rat treated with the oxime HI-6 alone combined with atropine, died within 24 hours following tabun challenge. The oxime HI-6 alone, as well as both oxime mixtures combined with atropine, were able to decrease tabun-induced neurotoxicity in the case of sublethal poisonings, but they did not eliminate all tabun-induced acute neurotoxic signs and symptoms. Their ability to reduce tabun-induced acute neurotoxcicity was almost the same, regardless of type of antidotal treatment. Thus, the tested combinations of oximes were not able to increase the neuroprotective effectiveness of the antidotal treatment of acute tabun poisonings compared to the individual oxime.
tabun; functional observational battery; neurotoxicity; mixture of oximes; rats
Bajgar J: Complex view on poisoning with nerve agents and organophosphates. Acta Med (Hradec Kralove) 48:3-21, 2005.
Cabal J, Bajgar J: Tabun - reappearance 50 years later (in Czech). Chem Listy 93:27-31, 1999.
Cassel G, Karlsson L, Waara L, Wee Ang K, Goransson-Nyberg A: Pharmacokinetics and effects of HI-6 in blood and brain of soman-intoxicated rats: a microdialysis study. Eur J Pharmacol 332:43-52, 1997.
Clement JG, Shiloff JD, Gennings Ch: Efficacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime, against tabun and soman poisoning of mice. Arch Toxicol 61:70-75, 1987.
Dawson RM: Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 14:317-331, 1994.
Ekstrom F, Akfur C, Tunemalm AK, Lundberg S: Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase. Biochemistry 45:74-81, 2006.
Frantik E, Hornychova M: Clustering of neurobehavioral measures of toxicity. Homeostasis 36:19-25, 1995.
Hornychova M, Frantik E, Kubat J, Formanek J: Neurotoxicity profile of supermethrin, a new pyrethroid insecticide. Cent Eur J Publ Health 3:210-218, 1995.
Jokanovic M: Anticholinesterase activity and delayed neurotoxic effects of tabun in hens. Vojnosamit Pregl 50:451-456, 1993.
Jokanovic M, Maksimovic M, Kilibarda V, Jovanovic D, Savic D: Oxime-induced reactivation of acetycholinesterase inhibited by phosphoramidates. Toxicol Lett 85:35-39, 1996.
Kalasz H, Laufer R, Szegi P, Kuca K, Musilek K, Tekes K: HPLC study of the pharmacokinetics of K-203. Acta Chromatogr 20:575-584, 2008.
Kassa J, Cabal J: A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods. Toxicology 132:111-118, 1999.
Kassa J, Karasova J: The evaluation of the neuroprotective effects of bispyridinium oximes in tabun-poisoned rats. J Toxicol Environ Health A 70:1556-1567, 2007.
Kassa J, Karasova J, Musilek K, Kuca K: An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Toxicology 243:311-316, 2008a.
Kassa J, Zdarova Karasova J, Tesarova S, Kuca K, Musilek K: A comparison of the neuroprotective efficacy of newly developed oximes (K156, K203) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats. Acta Med (Hradec Kralove) 51:215-221, 2008b.
Kassa J, Karasova J, Vasina L, Bajgar J, Kuca J, Musilek K: A comparison of neuroprotective efficacy of newly developed oximes (K203, K206) and commonly used oximes (obidoxime, HI-6) in tabun-poisoned rats. Drug Chem Toxicol 32:128-138, 2009.
Kassa J, Krejcova G: Neuroprotective effects of currently used antidotes in tabun-poisoned rats. Pharmacol Toxicol 92:258-264, 2003.
Kassa J, Kuca K, Bartosova L, Kunesova G: The development of new structural analogues of oximes for the antidotal treatment of poisoning by nerve agents and the comparison of their reactivating and therapeutic efficacy with currently available oximes. Curr Org Chem 11:267-283, 2007.
Kovacevic V, Maksimovic M, Pantelic D, Vojvodic V, Binenfeld Z: Protective and reactivating effects of HI-6 PAM-2 mixture in rats poisoned with nerve chemical warfare agents. Acta Pharm Jugosl 39:161-165, 1989.
Kovacevic V, Maksimovic M, Deljac V, Binenfeld Z: Protective effects of mixture of oximes in poisoning by nerve chemical warfare agents. Acta Pharm Jugosl 41:75-78, 1991.
Kovarik Z, Lucic Vrdoljak A, Berend S, Catalinic M, Kuca K, Musilek K, Radic B: Evaluation of oxime K203 as antidote in tabun poisoning. Arh Hig Rada Toksikol 60:19-26, 2009.
Kuca K, Musilek K, Stodulka P, Marek J, Hanusova P, Jun D, Hrabinova M, Kassa J, Dolezal B: Twelve different HI-6 salts and their potency to reactivate cyclosarin inhibited AChE in vitro. Lett Drug Des Discov 4:510-512, 2007.
Lawrence DT, Kirk MA: Chemical terrorism attacks: update on antidotes. Emerg Med Clin North Am 25:567-595, 2007.
Lorke DE, Kalasz H, Petroianu GA, Tekes K: Entry of oximes into the brain: A review. Curr Med Chem 15:743-753, 2008.
Lotti M: Organophosphorus compounds. In Spencer PS, Schaumburg HH (eds): Experimental and Clinical Neurotoxicology, Oxford University Press, New York 2000, pp. 898-925.
Lundy PM, Raveh L, Amitai G: Development of the bisquaternary oxime HI-6 toward clinical use in the treatment of organophosphate nerve agent poisoning. Toxicol Rev 25:231-243, 2006.
Maksimovic M, Kovacevic V: Protective and reactivating effects of HI-6-toxogonin mixture in rats and guinea-pigs poisoned by nerve agents. Acta Pharm Jugosl 39:27-33, 1989.
Marrs TC: Organophosphate poisoning. Pharmacol Ther 58:51-66, 1993.
Marrs TC, Rice P, Vale JA: The role of oximes in the treatment of nerve agent poisoning in civilian casualties. Toxicol Rev 25:297-323, 2006.
Maxwell DM, Koplovitz I, Worek F, Sweeney RE: A structure-activity analysis of the variation in oxime efficacy against nerve agents. Toxicol Appl Pharmacol 231:157-164, 2008.
Moser VC, Tilson H, McPhail RC, Becking GC, Cuomo V, Frantik E, Kulig BM, Winneke G: The IPCS collaborative study on neurobehavioral screening methods: II. Protocol design and testing procedures. Neurotoxicology 18:929-938, 1997.
Musilek K, Kuca K, Jun D, Dolezal M: Synthesis of bispyridinium compounds bearing propane linker and evaluation of their reactivation activity against tabun- and paraoxon-inhibited acetylcholinesterase. Lett Org Chem 3:831-835, 2006.
Musilek K, Kuca K, Jun D, Dolezal M: Progress in synthesis of new acetylcholinesterase reactivators in period 1990-2004. Curr Org Chem 11:229-238, 2007a.
Musilek K, Jun D, Cabal J, Kassa J, Gunn-Moore F, Kuca K: Design of a potent reactivator of tabun-inhibited acetylcholinesterase - synthesis and evaluation of (E)-1-(4-carbamoyl- pyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203). J Med Chem 50:5514-5518, 2007b.
Musilek K, Holas O, Jun D, Dohnal V, Gunn-Moore F, Opletalova V, Dolezal M, Kuca K: Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker - Preparation and reactivation of tabun and paraoxon-inhibited acetylcholinesterase. Bioorg Med Chem 15:6733-6741, 2007c.
Musilek K, Holas O, Kuca K, Jun D, Dohnal V, Opletalova V, Dolezal M: Synthesis of monooxime-monocarbamoyl bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against tabun- and paraoxon-inhibited acetylcholinesterase. J Enzyme Inhib Med Chem 23:70-76, 2008.
Ohtomi S, Takase M, Kumagai F: Sarin poisoning in Japan. A clinical experience in Japan Self Defense Force (JSDF) Central Hospital. Int Rev Arm Ser 69:97-102, 1996.
Puu G, Artursson E, Bucht G: Reactivation of nerve agent inhibited acetylcholinesterase by HI-6 and obidoxime. Biochem Pharmacol 35:1505-1510, 1986.
Roth Z, Josifko M, Maly V, Trcka V: Statistical Methods in Experimental Medicine (in Czech), SZN Praha 1962.
Sakurada K, Matsubara K, Shimizu K, Shiono H, Seto Y, Tsuge K, Toshibo M, Sakai I, Mukoyama H, Takatori T: Pralidoxime iodide (2-PAM) penetrates across the blood-brain barrier. Neurochem Res 28:1401-1407, 2003.
Taylor P: Anticholinesterase agents. In Hardman JG, Limbird LE (eds): The Pharmacological Basis of Therapeutics. McGraw Hill, New York 1996, pp. 161-176.
Worek F, Aurbek N, Thiermann H: Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro. J Appl Toxicol 27:582-588, 2007.
Worek F, Diepold C, Eyer P: Dimethylphosphoryl-inhibited human cholinesterases: inhibition, reactivation, and aging kinetics. Arch Toxicol 73:7-14, 1999.
Worek F, Widmann R, Knopff O, Szinicz L: Reactivating potency of obidoxime, pralidoxime, HI-6 and HLo-7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch Toxicol 72:237-243, 1998.
Soukup O, Kumar UK, Proska J, Bratova L, Adem A, Jun D, Fusek J, Kuca K, Tobin G. The effect of oxime reactivators on muscarinic receptors: Functional and binding examinations. Environ Toxicol Pharmacol. 31: 364-370, 2011.
Soukup O, Holas O, Binder J, Killy K, Tobin G, Jun D, Fusek J, Kuca K. The effect of trimedoxime on acetylcholinesterase and on the cholinergic system of the rat bladder. J Appl Biomed. 8: 87-92, 2010.